Trends and Patterns of Hepatocellular Carcinoma Treatment in Korea

Area of Science:

• Hepatobiliary Medicine
• Oncology
• Health Services Research

Background:

• Hepatocellular carcinoma (HCC) is a significant global health concern.
• Multiple treatment options exist for HCC, including surgical, radiological, and chemotherapeutic approaches.
• Understanding treatment trends is crucial for optimizing patient care and resource allocation.

Purpose of the Study:

• To evaluate the evolving trends and patterns of HCC treatment modalities in Korea.
• To analyze the utilization of different therapies for initial and subsequent treatments of HCC.
• To assess the interchangeability of treatment modalities in HCC management.

Main Methods:

• Retrospective analysis of HCC patient data from the Korean Health Insurance Review Assessment Service (2008-2012).
• Inclusion of patients newly diagnosed with HCC between 2009 and 2012 (n=57,690).
• Assessment of initial treatment modalities and re-treatment patterns following hepatic resection, local ablation, and transcatheter arterial chemoembolization (TACE).

Main Results:

• Transcatheter arterial chemoembolization (TACE) was the most frequent initial treatment for HCC.
• Curative modalities such as hepatic resection, liver transplantation, and local ablation therapy showed a gradual increase.
• Re-treatment rates were high across initial treatment groups, with TACE being a common subsequent therapy, indicating treatment interchangeability.

Conclusions:

• Transcatheter arterial chemoembolization (TACE) remains a dominant initial treatment for HCC in Korea.
• There is a growing trend towards utilizing curative and less invasive therapies.
• HCC management frequently involves sequential or interchangeable treatment modalities, highlighting the need for flexible treatment strategies.